200 Barr Harbor Drive
West Conshohocken, PA 19428
Resmetirom is an investigational therapy and has not been approved by the FDA (or any other regulatory authority). Resmetirom
is only available for use in a clinical trial setting (ClinicalTrials.gov NCT03900429 and NCT04197479)
Website Developed by Alan Leff Associates, Inc.